Legend Biotech (LEGN) Gross Profit Growth (1y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 16.94% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,488.21% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75.94% |
| Sep 30, 2025 | 89.52% |
| Jun 30, 2025 | 32.31% |
| Mar 31, 2025 | 120.85% |
| Dec 31, 2024 | -99.83% |
| Sep 30, 2024 | 54.76% |
| Jun 30, 2024 | 201.46% |
| Mar 31, 2024 | 279.55% |
| Dec 31, 2023 | 4,390,174.38% |
| Sep 30, 2023 | 780.42% |
| Jun 30, 2023 | 435.52% |
| Mar 31, 2023 | -36.04% |
| Dec 31, 2022 | 113.10% |
| Sep 30, 2022 | 421.09% |
| Jun 30, 2022 | -548.25% |
| Mar 31, 2022 | 100.21% |
| Dec 31, 2021 | -183.22% |
| Sep 30, 2021 | -207.72% |
| Jun 30, 2021 | 68.92% |
| Mar 31, 2021 | -268,112.76% |
| Dec 31, 2020 | 173.22% |
| Sep 30, 2020 | -81.38% |
| Jun 30, 2020 | -59.60% |